UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 296

Sortiert nach

Herpes simplex viruses activate phospholipid scramblase to redistribute phosphatidylserines and Akt to the outer leaflet of the plasma membrane and promote viral entry

PLoS pathogens, 2018-01, Vol.14 (1), p.e1006766-e1006766

2018

Volltextzugriff (PDF)

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

Science translational medicine, 2020-10, Vol.12 (564)

2020

Volltextzugriff (PDF)

Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City

The Journal of pediatrics, 2020-08, Vol.223, p.14-19.e2

2020

Volltextzugriff (PDF)

Natural mucosal barriers and COVID-19 in children

JCI insight, 2021-05, Vol.6 (9)

2021

Volltextzugriff (PDF)

Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli

PloS one, 2014-05, Vol.9 (5), p.e96659-e96659

2014

Volltextzugriff (PDF)

COVID-19 and children

Science (American Association for the Advancement of Science), 2022-09, Vol.377 (6611), p.1144-1149

2022

Volltextzugriff (PDF)

HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal

The Journal of clinical investigation, 2023-06, Vol.133 (11)

2023

Volltextzugriff (PDF)

Visual Hallucinations and Headache in a Returning Adolescent Traveler

Clinical pediatrics, 2024-05, p.99228241254607-99228241254607

2024

Volltextzugriff (PDF)

Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk

PloS one, 2015-03, Vol.10 (3), p.e0121135

2015

Volltextzugriff (PDF)

Alphaherpesvirus Vaccines

Current issues in molecular biology, 2021, Vol.41, p.469-508

2021

Volltextzugriff (PDF)

Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection

PloS one, 2019-04, Vol.14 (4), p.e0216049-e0216049

2019

Volltextzugriff (PDF)

A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice

The Journal of clinical investigation, 2023-02, Vol.133 (3), p.1-15

2023

Volltextzugriff (PDF)

50 Years Ago in The Journal of Pediatrics: Revisiting a Diagnostic Dilemma 50 Years Later: Partially Treated Bacterial Meningitis

The Journal of pediatrics, 2020-10, Vol.225, p.102-102

2020

Volltextzugriff (PDF)

A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2

The Journal of infectious diseases, 2018-02, Vol.217 (5), p.754-758

2018

Volltextzugriff (PDF)

Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread

Journal of Virology, 2013-06, Vol.87 (11), p.6257-6269

2013

Volltextzugriff (PDF)

We Need to Address the Health of Children at the Border

Clinical infectious diseases, 2020-06, Vol.70 (12), p.2724-2726

2020

Volltextzugriff (PDF)

Failure of Herpes Simplex Virus Glycoprotein D Antibodies to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines

The Journal of infectious diseases, 2022-11, Vol.226 (9), p.1489-1498

2022

Volltextzugriff (PDF)

IgA coating of vaginal bacteria is reduced in the setting of bacterial vaginosis (BV) and preferentially targets BV-associated species

Infection and immunity, 2024-01, Vol.92 (1), p.e0037323

2024

Volltextzugriff (PDF)

Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2

The Journal of infectious diseases, 2020-02, Vol.221 (5), p.729-738

2020

Volltextzugriff (PDF)

Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease

eLife, 2015-03, Vol.4

2015

Volltextzugriff (PDF)

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy

PloS one, 2017-07, Vol.12 (7), p.e0180245-e0180245

2017

Volltextzugriff (PDF)

Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators

PloS one, 2011-08, Vol.6 (8), p.e23136-e23136

2011

Volltextzugriff (PDF)

1 – 25 von 296

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(268)

Publikationsform

Sprache

Englisch
(296)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(211)
Life Sciences & Biomedicine
(191)
Humans
(166)
Female
(128)
Infectious Diseases
(79)
Immunology
(75)
Biological And Medical Sciences
(69)
Animals
(61)
Medical Sciences
(61)
Human Immunodeficiency Virus
(57)
Virology
(52)
Hiv
(50)
Male
(48)
Microbiology
(48)
Pediatrics
(45)
Adult
(44)
Adolescent
(29)
Child
(29)
Hiv Infections - Prevention & Control
(29)
Herpes Simplex Virus
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Herpes simplex viruses activate phospholipid scramblase to redistribute phosphatidylserines and Akt to the outer leaflet of the plasma membrane and promote viral entry

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City

Natural mucosal barriers and COVID-19 in children

Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli

COVID-19 and children

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women

Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth

HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study

Visual Hallucinations and Headache in a Returning Adolescent Traveler

Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk

Alphaherpesvirus Vaccines

Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection

A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice

50 Years Ago in The Journal of Pediatrics: Revisiting a Diagnostic Dilemma 50 Years Later: Partially Treated Bacterial Meningitis

A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2

Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread

We Need to Address the Health of Children at the Border

Failure of Herpes Simplex Virus Glycoprotein D Antibodies to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines

IgA coating of vaginal bacteria is reduced in the setting of bacterial vaginosis (BV) and preferentially targets BV-associated species

Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2

Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy

Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators

Suchergebnisse filtern